We are live on ! Find out more
AA

ABC Arbitrage Portfolio holdings

AUM $926M
1-Year Est. Return 45.9%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+45.9%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$52.3M
Cap. Flow
-$17.4M
Cap. Flow %
-1.63%
Top 10 Hldgs %
36.49%
Holding
431
New
231
Increased
44
Reduced
32
Closed
118

Top Buys

Rank Stock Value
1
HMY icon
Harmony Gold Mining
HMY
+$27.4M
2
GSK icon
GSK
GSK
+$23.4M
3
NVS icon
Novartis
NVS
+$23.1M
4
DEO icon
Diageo
DEO
+$13M
5
BCS icon
Barclays
BCS
+$13M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$47.5M
2
TS icon
Tenaris
TS
+$27.7M
3
SBSW icon
Sibanye-Stillwater
SBSW
+$27.6M
4
RELX icon
RELX
RELX
+$23.1M
5
STM icon
STMicroelectronics
STM
+$17.5M

Sector Composition

Rank Sector Weight
1 Financials 22.09%
2 Healthcare 15.65%
3 Consumer Staples 11.29%
4 Materials 11.29%
5 Technology 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTI icon
1
British American Tobacco
BTI
$134B
$52M 4.87%
918,653
+147,630
+19% +$8.06M
HMY icon
2
Harmony Gold Mining
HMY
$9.75B
$49.5M 4.64%
2,488,874
+1,467,370
+144% +$27.4M
DEO icon
3
Diageo
DEO
$49.3B
$48.3M 4.53%
560,383
+141,301
+34% +$13M
VOD icon
4
Vodafone
VOD
$37.7B
$42.6M 3.99%
3,227,589
-418,823
-11% -$5.07M
ERIC icon
5
Ericsson
ERIC
$32.8B
$42.4M 3.97%
4,389,009
+1,179,194
+37% +$11.2M
BCS icon
6
Barclays
BCS
$91.1B
$39.4M 3.69%
1,546,396
+586,115
+61% +$13M
CUK
7
DELISTED
Carnival PLC
CUK
$30.6M 2.86%
1,008,794
+12,219
+1% +$315K
GSK icon
8
GSK
GSK
$107B
$28.4M 2.66%
578,392
+501,590
+653% +$23.4M
HSBC icon
9
HSBC
HSBC
$356B
$28.3M 2.65%
360,332
+116,163
+48% +$8.31M
HLN icon
10
Haleon
HLN
$45.2B
$28.2M 2.64%
2,789,451
+62,101
+2% +$590K
RIO icon
11
Rio Tinto
RIO
$149B
$27.1M 2.54%
338,891
-56,530
-14% -$4.07M
NWG icon
12
NatWest
NWG
$70.8B
$24.9M 2.34%
1,425,146
+322,175
+29% +$5.11M
SBSW icon
13
Sibanye-Stillwater
SBSW
$5.93B
$24.9M 2.33%
1,749,026
-2,283,786
-57% -$27.6M
SNN icon
14
Smith & Nephew
SNN
$13.7B
$24.9M 2.33%
757,956
+74,504
+11% +$2.55M
NVS icon
15
Novartis
NVS
$304B
$24.4M 2.28%
+176,749
New +$23.1M
NGG icon
16
National Grid
NGG
$81.7B
$24.1M 2.26%
312,202
+69,204
+28% +$5.21M
SHEL icon
17
Shell
SHEL
$239B
$23.6M 2.21%
321,821
+140,966
+78% +$10.4M
AEG icon
18
Aegon
AEG
$13.5B
$16.2M 1.51%
2,097,310
+15,442
+0.7% +$118K
ING icon
19
ING
ING
$95.2B
$15.6M 1.46%
556,894
-344,042
-38% -$8.87M
IHG icon
20
InterContinental Hotels
IHG
$23.9B
$14.4M 1.35%
102,505
-28,872
-22% -$3.75M
FXI icon
21
iShares China Large-Cap ETF
FXI
$4.27B
$13.9M 1.3%
362,554
-44,553
-11% -$1.77M
AZN icon
22
AstraZeneca
AZN
$266B
$12.9M 1.21%
70,075
-270,606
-79% -$47.5M
BP icon
23
BP
BP
$108B
$12.9M 1.21%
370,972
+41,260
+13% +$1.45M
RTO icon
24
Rentokil
RTO
$14.5B
$10.9M 1.02%
369,604
-64,968
-15% -$1.8M
UL icon
25
Unilever
UL
$144B
$7.68M 0.72%
117,480
+40,036
+52% +$2.69M
1
2 3 4 5

Similar funds

ICM
Innovator Capital Management Wheaton, Illinois $925M AUM 49.11% 1-Year Est. Return
TC
Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return
CFA
Cahill Financial Advisors Edina, Minnesota $924M AUM 16.55% 1-Year Est. Return
VCAM
Van Cleef Asset Management Beachwood, Ohio $929M AUM 13.28% 1-Year Est. Return
WC
Westerkirk Capital Victoria $929M AUM 21.93% 1-Year Est. Return
MHIC
Marble Harbor Investment Counsel Boston, Massachusetts $923M AUM 14.09% 1-Year Est. Return
BCC
Biglari Capital Corp San Antonio, Texas $929M AUM 39.8% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

ABC Arbitrage's Q4 2025 Portfolio in Review

As of Q4 2025, ABC Arbitrage held 431 positions worth $1.07B, up 5.2% from $1.02B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

ABC Arbitrage's Q4 2025 filing shows 231 new, 44 increased, 32 reduced and 118 closed positions. Its largest new stake was Novartis: 176,749 shares worth $24.4M. The largest sale was AstraZeneca, an estimated $47.5M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Staples.

  • ABC Arbitrage's largest Q4 2025 buy was Novartis: 176,749 shares worth $24.4M.
  • ABC Arbitrage added most to Harmony Gold Mining in Q4 2025, an estimated $27.4M increase.
  • ABC Arbitrage's biggest Q4 2025 reduction was AstraZeneca, cutting an estimated $47.5M.
  • ABC Arbitrage fully exited Tenaris in Q4 2025, selling an estimated $27.7M.
  • ABC Arbitrage's ten largest holdings make up 36% of its $1.07B portfolio in Q4 2025.
  • ABC Arbitrage opened 231 new positions and closed 118 in Q4 2025.
  • ABC Arbitrage's portfolio value rose 5.2% quarter-over-quarter to $1.07B.

Based on ABC Arbitrage's 13F filing for Q4 2025, filed 4 Feb 2026.